Edition:
United States

Aspen Technology Inc (AZPN.OQ)

AZPN.OQ on NASDAQ Stock Exchange Global Select Market

64.24USD
19 Sep 2017
Change (% chg)

-- (--)
Prev Close
$64.24
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
220,526
52-wk High
$64.87
52-wk Low
$45.17

Chart for

About

Aspen Technology, Inc. is a global provider of process optimization software solutions designed to manage and optimize plant and process design, operational performance, and supply chain planning. The Company's aspenONE software and related services have been developed specifically for companies in the process industries,... (more)

Overall

Beta: 1.25
Market Cap(Mil.): $4,695.89
Shares Outstanding(Mil.): 73.10
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 19.74 16.25
EPS (TTM): -- -- --
ROI: -- 16.19 14.87
ROE: -- 18.29 13.89

CORRECTED-South Africa's Aspen Pharmacare flags jump in full-year profit

JOHANNESBURG, Aug 30 South African drugmaker Aspen Pharmacare said on Wednesday that it expects full-year profit to climb by as much as 48 percent from last year when it was hit by a writedown on its Venezuelan business.

Aug 30 2017

BRIEF-Aspen Technology Q4 non-GAAP earnings per share $0.79

* Aspen Technology announces financial results for the fourth quarter and fiscal year 2017

Aug 10 2017

Aspen under EU antitrust spotlight over excessive cancer drug prices

BRUSSELS EU antitrust regulators will investigate whether Aspen Pharmacare is charging excessive prices for five key cancer drugs in a move which could lead to a hefty fine for Africa's largest generic drugmaker.

May 15 2017

UPDATE 2-Aspen under EU antitrust spotlight over excessive cancer drug prices

BRUSSELS, May 15 EU antitrust regulators will investigate whether Aspen Pharmacare is charging excessive prices for five key cancer drugs in a move which could lead to a hefty fine for Africa's largest generic drugmaker.

May 15 2017

Aspen under EU antitrust spotlight over excessive cancer drug prices

BRUSSELS EU antitrust regulators will investigate whether Aspen Pharmacare is charging excessive prices for five key cancer drugs in a move which could lead to a hefty fine for Africa's largest generic drugmaker.

May 15 2017

BRIEF-Aspen Technology announces Q3 earnings per share $0.47

* Aspen Technology announces financial results for the third quarter of fiscal 2017

May 02 2017

Earnings vs. Estimates